Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Wound care biologic products facilitates in innate repair mechanisms, and involves the use of active biological agents such as animal and plant-derived active biomolecules, which exhibit antioxidant, antimicrobial, or anti-inflammatory properties. Wound care biologic dressings are increasingly being used in post surgeries and severe trauma cases as they provide moist healing environment aiding heat loss, protein and electrolyte loss for faster healing, and prevent bacterial contamination. Biologic skin substitute products include tissue-engineered products, which are designed to either temporarily or permanently replace the altered skin. Skin substitutes are commonly used products for wound management and have application for treating various ailments such as pressure ulcers, diabetic neuropathic ulcers, and vascular insufficiency ulcers.
Market Dynamics
Increasing incidences of chronic ulcers, owing to rising prevalence of diabetes, increasing surgical procedures, and rise in trauma cases are major driving factors for growth of wound care biologics market. According to the survey by World Health Organization, 2014, injuries resulting from traffic collisions, drowning, poisoning, falls or burns account for 9% of the global mortality. Also, according to a study by BMJ Journal Injury Prevention, 2013, an estimated 973 million people sustained injuries that warranted some type of healthcare and 4.8 million people died from injuries. The Journal also stated that major injury causes included road injury (29.1%), self-harm (17.6%), falls (11.6%), and interpersonal violence (8.5%). Manufacturers are also focused on extensive research and development to develop new products and expand their product portfolio. For instance, in 2016, Integra LifeSciences Holdings Corporation received FDA approval for Integra Dermal Regeneration Template (IDRT) for the treatment of diabetic foot ulcers that is marketed under the name of Integra Omnigraft Dermal Regeneration Matrix. Moreover, public awareness for biologics has positively contributed to the market growth, as people are opting for enhanced medical care for preventing wounds to minimize the morbidity associated with the formation of chronic wounds. However, higher cost of the biologics and stringent regulatory approvals for launch of innovative tissue engineered products are hindering growth of the wound care biologics market.
Key features of the study:
This report provides in-depth analysis of wound care biologics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global wound care biologics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
Key companies covered as a part of this study include Smith & Nephew Plc., Organogenesis, Inc., Integra Lifesciences Holdings Corporation, Skye Biologics, Alphatec Holdings, Inc., Solsys Medical LLC, Amino Technology LLC, and Osiris Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global wound care biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the wound care biologics market
Detailed Segmentation:
Global Wound Care Biologics Market, By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
Global Wound Care Biologics Market, By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
Global Wound Care Biologics Market, By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
Global Wound Care Biologics Market, By Geography:
North America
By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
By Country:
U.S.
Canada
Latin America
By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Biologic Skin Substitutes
Enzyme Based Formulations
Growth factors
By Application:
Chronic Wounds
Diabetic Foot Ulcers
Venous Leg Ulcers
Pressure Ulcers
Acute Wounds
Surgical Wounds
Burns
By End User:
Hospitals
In-patient Settings
Out-patient Settings
Clinics
Ambulatory Surgical Centers
Home Care Settings
By Country:
South Africa
Central Africa
North Africa
Company Profiles
Smith & Nephew Plc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Market Strategies
Organogenesis, Inc.
Integra Lifesciences Holdings Corporation
Skye Biologics
Alphatec Holdings, Inc.
Solsys Medical LLC
Amino Technology LLC
Osiris Therapeutics, Inc.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Product Type
? Market Snippet, By Application
? Market Snippet, By End User
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
? Industry Trends
o Technological Advancements
o Regulatory Scenario
o Reimbursement Scenario
o Key Highlights
o PEST Analysis
o Epidemiology
o Impact Analysis
4. Global Wound Care Biologics Market, By Product Type, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Biologic Skin Substitutes
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Enzyme Based Formulations
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Growth Factors
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
5. Global Wound Care Biologics Market, By Application, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Chronic Wounds
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
? Segment Trends
? Diabetic Foot Ulcers
? Venous Leg Ulcers
? Pressure Ulcers
o Acute Wounds
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
? Segment Trends
? Surgical Wounds
? Burns
6. Global Wound Care Biologics Market, By End User, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, 2016-2025
? Segment Trends
o Hospitals
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
? Segment Trends
? In-patient Settings
? Out-patient Settings
o Clinics
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Ambulatory Surgical Centers
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
o Home Care Settings
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2015-2025, (US$ Million)
7. Global Wound Care Biologics Market, By Region, 2015-2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2015 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2016-2025
o North America
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Country, 2015-2025, (US$ Million)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Country, 2015-2025, (US$ Million)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Europe
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Country, 2015-2025, (US$ Million)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Country, 2015-2025, (US$ Million)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Country, 2015-2025, (US$ Million)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Product Type, 2015-2025, (US$ Million)
? Market Size and Forecast, By Application, 2015-2025, (US$ Million)
? Market Size and Forecast, By End User, 2015-2025, (US$ Million)
? Market Size and Forecast, By Country, 2015-2025, (US$ Million)
? South Africa
? Central Africa
? North Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
? Smith & Nephew Plc.*
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Organogenesis, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Integra Lifesciences Holdings Corporation
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Skye Biologics
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Alphatec Holdings, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Solsys Medical LLC
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Amino Technology LLC
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
? Osiris Therapeutics, Inc.
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 38 market data tables and 26 figures on "Wound Care Biologics Market - Global forecast to 2025".
